| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
1,095,971,000 |
| Market
Cap: |
18.03(B) |
| Last
Volume: |
5,132,747 |
Avg
Vol: |
10,637,630 |
| 52
Week Range: |
$7.2 - $17.09 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ-100 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Teva Pharmaceutical Industries is a pharmaceutical company. Co. operates through three segments: North America, which includes the U.S. and Canada; Europe, which includes the European Union and certain other European countries; and International Markets, which includes all countries in which Co. operates other than those in Co.'s North America and Europe segments. Co.'s products include: AUSTEDO; AJOVY (anti calcitonin gene-related peptide); COPAXONE; BENDEKA and TREANDA; ProAir HFA; ProAir RespiClick; QVAR; QVAR RediHaler; ProAir Digihaler; ArmonAir Digihaler; AirDuo Digihaler; BRALTUS®; CINQAIR/CINQAERO; and AirDuo RespiClick.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
409,360 |
720,697 |
810,545 |
1,346,844 |
| Total Sell Value |
$5,648,346 |
$9,700,206 |
$10,499,443 |
$15,688,359 |
| Total People Sold |
7 |
8 |
8 |
10 |
| Total Sell Transactions |
11 |
17 |
20 |
34 |
| End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Conway Vikki L |
See Remarks |
• – – |
2024-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,179 |
8,107 |
|
- |
|
| Drape Eric |
Executive VP Global Operations |
• – – |
2024-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,900 |
44,416 |
|
- |
|
| Daniell Richard |
Exec. VP, European Commercial |
• – – |
2024-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
62,250 |
132,020 |
|
- |
|
| Kalif Eliyahu Sharon |
EVP, Chief Financial Officer |
• – – |
2024-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
49,800 |
174,022 |
|
- |
|
| Sabag Mark |
EVP, International Markets |
• – – |
2024-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,900 |
367,181 |
|
- |
|
| Francis Richard D |
President and CEO |
• – – |
2024-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
67,231 |
154,356 |
|
- |
|
| Conway Vikki L |
See Remarks |
• – – |
2024-02-28 |
4 |
AS |
$13.12 |
$17,916 |
D/D |
(1,366) |
2,928 |
|
27% |
|
| Conway Vikki L |
See Remarks |
• – – |
2024-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,294 |
4,294 |
|
- |
|
| Bergwerk Dov |
Acting Chief Legal Officer |
• – – |
2024-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,653 |
96,983 |
|
- |
|
| Weiss Amir |
Chief Accounting Officer |
• – – |
2024-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,219 |
13,895 |
|
- |
|
| Sabag Mark |
EVP, International Markets |
• – – |
2024-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,599 |
342,281 |
|
- |
|
| Drape Eric |
Executive VP Global Operations |
• – – |
2024-02-28 |
4 |
AS |
$13.12 |
$128,734 |
D/D |
(9,815) |
9,701 |
|
27% |
|
| Drape Eric |
Executive VP Global Operations |
• – – |
2024-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,515 |
19,516 |
|
- |
|
| Daniell Richard |
Exec. VP, European Commercial |
• – – |
2024-02-28 |
4 |
AS |
$13.12 |
$270,176 |
D/D |
(20,599) |
69,770 |
|
27% |
|
| Daniell Richard |
Exec. VP, European Commercial |
• – – |
2024-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,599 |
90,369 |
|
- |
|
| Kalif Eliyahu Sharon |
EVP, Chief Financial Officer |
• – – |
2024-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,430 |
124,222 |
|
- |
|
| Drape Eric |
Executive VP Global Operations |
• – – |
2024-02-16 |
4 |
S |
$13.05 |
$2,261,905 |
D/D |
(173,261) |
1 |
|
-29% |
|
| Francis Richard D |
President and CEO |
• – – |
2024-02-15 |
4 |
AS |
$13.15 |
$980,174 |
D/D |
(74,530) |
87,125 |
|
26% |
|
| Francis Richard D |
President and CEO |
• – – |
2024-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
161,655 |
161,655 |
|
- |
|
| Kalif Eliyahu Sharon |
EVP, Chief Financial Officer |
• – – |
2024-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,630 |
105,792 |
|
- |
|
| Weiss Amir |
Chief Accounting Officer |
• – – |
2024-02-01 |
4 |
S |
$12.37 |
$392,955 |
D/D |
(31,766) |
10,676 |
|
-35% |
|
| Bergwerk Dov |
Acting Chief Legal OfficerOffi |
• – – |
2023-10-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
90,330 |
|
49% |
|
| Kalif Eliyahu Sharon |
EVP, Chief Financial Officer |
• – – |
2023-08-07 |
4 |
S |
$9.73 |
$341,889 |
D/D |
(35,125) |
99,162 |
|
-5% |
|
| Mignone Roberto |
Director |
– • – |
2023-08-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,810 |
1,574,575 |
|
- |
|
| Lieberman Gerald M |
Director |
– • – |
2023-08-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,810 |
84,917 |
|
- |
|
524 Records found
|
|
Page 2 of 21 |
|
|
0.31 (1.85%) 
